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Introduction As a causal organism in infective endocarditis, Burkholderia pseudomallei is rare. Burkholderia pseudomallei is intrinsically
resistant to aminoglycosides but a gentamicin-susceptible strain was discovered in Sarawak, Malaysian Borneo in 2010.




A 29-year-old man presented with pneumonia and melioidosis septicaemia. His condition was complicated with in-
fective endocarditis and septic emboli to the brain. Despite difficulties in reaching a diagnosis, the patient was suc-
cessfully treated using intravenous gentamicin and ceftazidime and was discharged well.
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Discussion The role of gentamicin in the treatment of the gentamicin-susceptible strain of B. pseudomallei remains unclear.
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Introduction
Melioidosis is caused by the bacterium Burkholderia pseudomallei. It
is endemic in many regions in Southeast Asia and Northern
Australia.1 It is also increasingly reported in other tropical coun-
tries.1 It has a high mortality rate due to its systemic involvement
and intrinsic resistance to a myriad of antibiotics.2 A novel strain
of gentamicin-susceptible B. pseudomallei was recently reported to
be predominantly found in the central region of Sarawak in
Malaysian Borneo.3
Infective endocarditis causes significant morbidity and mortality.4,5
Complications of infective endocarditis include thromboembolic
events, which could be life-threatening. Treatment of infective endo-
carditis requires the administration of an effective intravenous (IV)
antibiotic over a prolonged duration.6 Common organisms identified
for infective endocarditis are Streptococci and Staphylococci, both of
which contributed to 80% of cases.6
We report the first occurrence of infective endocarditis due to
the gentamicin-susceptible strain of B. pseudomallei in a tertiary hos-
pital in central Sarawak of Malaysian Borneo.
Learning points
• Burkholderia pseudomallei is an unusual cause of infective endocarditis.
• Burkholderia pseudomallei is known to be resistant to many antibiotics, including aminoglycosides. A strain of B. pseudomallei that is gentami-
cin-susceptible was found in Sarawak in Malaysian Borneo in 2010.
• The standard intensive phase therapy using carbapenem or ceftazidime can be instituted together with intravenous gentamicin for its syner-
gistic effect in the treatment of infective endocarditis caused by the gentamicin susceptible strain of B. pseudomallei.
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